Bogle Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bogle Investment Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,000	Closed	-$221K	–	142
2020 Q4	$221K	Buy	+13,000	New	+$163K	0.35%	142
2018 Q4	–	Sell	-136,029	Closed	-$1.89M	–	443
2018 Q3	$1.89M	Buy	136,029 +104,051	+325%	+$1.55M	0.14%	147
2018 Q2	$506K	Sell	31,978 -39,574	-55%	-$691K	0.04%	243
2018 Q1	$1.23M	Buy	+71,552	New	+$1.4M	0.09%	188
2016 Q4	–	Sell	-333,449	Closed	-$17.5M	–	436
2016 Q3	$17.5M	Buy	333,449 +5,120	+2%	+$244K	1.26%	5
2016 Q2	$13.6M	Buy	+328,329	New	+$14.3M	0.94%	11
2016 Q1	–	Sell	-66,477	Closed	-$2.76M	–	487
2015 Q4	$2.76M	Buy	+66,477	New	+$2.23M	0.2%	149
2015 Q2	–	Sell	-171,155	Closed	-$3.91M	–	451
2015 Q1	$3.91M	Sell	171,155 -9,963	-6%	-$251K	0.27%	111
2014 Q4	$4.89M	Buy	+181,118	New	+$3.12M	0.32%	108

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bogle Investment Management's FPRX Position: Q1 2021 in Review

Bogle Investment Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 13,000 shares — an estimated $221K sold.

Bogle Investment Management first reported a position in FPRX in Q4 2014 and held it in 9 quarters. The position peaked at $17.5M in Q3 2016. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

Bogle Investment Management reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Bogle Investment Management sold 13,000 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $221K.
Bogle Investment Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 9 quarters.
Bogle Investment Management's Five Prime Therapeutics, Inc. position peaked at $17.5M in Q3 2016.
147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on Bogle Investment Management's 13F filing for Q1 2021.